Management of ventricular arrhythmias: A trial-based approach

Journal of the American College of Cardiology

Volumn 34, Issue 3, 1999, Pages 621-630

  Welch, Patrick J ^a,b   Page, Richard L ^a,b   Hamdan, Mohamed H ^a,b  

^a U   (United States)

^b VA NORTH TEXAS HEALTH CARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; ENCAINIDE; FLECAINIDE; MEXILETINE; QUINIDINE; SOTALOL;

ACUTE HEART INFARCTION; ANTIARRHYTHMIC ACTIVITY; CLINICAL TRIAL; DEFIBRILLATOR; DRUG EFFICACY; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HUMAN; PATIENT SELECTION; PRIMARY PREVENTION; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK FACTOR; RISK MANAGEMENT; TREATMENT OUTCOME;

EID: 0032880023     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(99)00273-9     Document Type: Article

References (62)

1. Myerburg R.J., Kessler K.M., Castellanos A. Sudden cardiac death. Structure, function, and time-dependence of risk. Circulation. 85:(Suppl 1):1992;I2-I10.
2. Doyle J.T., Kannel W.B., McNamara P.M., et al. Factors related to suddenness of death from coronary disease combined Albany-Framingham studies . Am J Cardiol. 37:1976;1073-1078.
3. Risk stratification after myocardial infarction. N Engl J Med. 309:1983;331-336.
4. Anderson K.P., DeCamilla J., Moss A.J. Clinical significance of ventricular tachycardia (3 beats or longer) detected during ambulatory monitoring after myocardial infarction. Circulation. 57:1978;890-897.
5. Kleiger R.E., Miller J.P., Thanavaro S., et al. Relationship between clinical features of acute myocardial infarction and ventricular runs 2 weeks to 1 year after infarction. Circulation. 63:1981;64-70.
6. Bigger J.T. Jr, Weld F.M., Rolnitzky L.M. Prevalence, characteristics and significance of ventricular tachycardia (three or more complexes) detected with ambulatory electrocardiographic recording in the late hospital phase of acute myocardial infarction. Am J Cardiol. 48:1981;815-823.
7. Bigger J.T., Fleiss J.L., Rolinitzky L.M. Prevalence, characteristics, and significance of ventricular tachycardia detected by 24-hour continuous electrocardiographic recordings in the late hospital phase of acute myocardial infarction. Am J Cardiol. 58:1986;1151-1160.
8. Kostis J.B., Byington R., Friedman L.M., et al. Prognostic significance of ventricular ectopic activity in survivors of acute myocardial infarction. J Am Coll Cardiol. 10:1987;231-242.
9. Moss A.J., Bigger J.T., Odoroff C.L. Postinfarct risk stratification. Prog Cardiovasc Dis. 29:1987;389-412.
10. Moss A.J. Identification of patients at increased risk for potentially malignant arrhythmias. Cardiovasc Drugs Ther. 4:1990;665-667.
11. Mukharji J., Rude R.E., Poole W.K., et al. Risk factors for sudden death after acute myocardial infarction two-year follow-up . Am J Cardiol. 54:1984;31-36.
12. Bigger J., Fleiss J., Kleiger R., Miller J. The relationships among ventricular arrhythmias, left ventricular dysfunction, and mortality in the two years after myocardial infarction. Circulation. 69:1984;250-258.
13. Denniss A.R., Richards D.A., Cody D.V., et al. Prognostic significance of ventricular tachycardia and fibrillation induced at programmed stimulation and delayed potentials detected on the signal-averaged electrocardiograms of survivors of acute myocardial infarction. Circulation. 74:1986;731-745.
14. Buxton A.E., Simson M.B., Falcone R.A., et al. Results of signal-averaged electrocardiography and electrophysiologic study in patients with nonsustained ventricular tachycardia after healing of acute myocardial infarction. Am J Cardiol. 60:1987;80-85.
15. Turitto G., Fontaine J.M., Ursell S.N., et al. Value of the signal-averaged electrocardiogram as a predictor of the results of programmed stimulation in nonsustained ventricular tachycardia. Am J Cardiol. 61:1988;1272-1278.
16. Winters S.L., Stewart D., Targonski A., Gomes J.A. Role of signal averaging of the surface QRS complex in selecting patients with nonsustained ventricular tachycardia and high grade ventricular arrhythmias for programmed ventricular stimulation. J Am Coll Cardiol. 12:1988;1481-1487.
17. Gomes J.A., Winters S.L., Stewart D., et al. A new noninvasive index to predict sustained ventricular tachycardia and sudden death in the first year after myocardial infarction based on signal-averaged electrocardiogram, radionuclide ejection fraction and holter monitoring . J Am Coll Cardiol. 10:1987;349-357.
18. Kuchar D.L., Thorburn C.W., Sammel N.L. Prediction of serious arrhythmic events after myocardial infarction signal-averaged electrocardiogram, Holter monitoring and radionuclide ventriculography . J Am Coll Cardiol. 9:1987;531-538.
19. Steinberg J.S., Regan A., Sciacca R.R., et al. Predicting arrhythmic events after acute myocardial infarction using the signal-averaged electrocardiogram. Am J Cardiol. 69:1992;13-21.
20. Prystowsky E.N., Miles W.M., Evans J.J., et al. Induction of ventricular tachycardia during programmed electrical stimulation analysis of pacing methods . Circulation. 73:1986;II32-II8.
21. Buxton A.E., Marchlinski F.E., Flores B.T., et al. Nonsustained ventricular tachycardia in patients with coronary artery disease role of electrophysiologic study . Circulation. 75:1987;1178-1185.
22. Klein R.C., Machell C. Use of electrophysiologic testing in patients with nonsustained ventricular tachycardia prognostic and therapeutic implications . J Am Coll Cardiol. 14:1989;155-163.
23. Manolis A.S., Estes N.A. Value of programmed ventricular stimulation in the evaluation and management of patients with nonsustained ventricular tachycardia associated with coronary artery disease. Am J Cardiol. 65:1990;201-205.
24. Wilber D.J., Olshansky B., Moran J.F., Scanlon P.J. Electrophysiological testing and nonsustained ventricular tachycardia. Use and limitations in patients with coronary artery disease and impaired ventricular function. [see comments]. Circulation. 82:1990;350-358.
25. Kowey P.R., Taylor J.E., Marinchak R.A., Rials S.J. Does programmed stimulation really help in the evaluation of patients with nonsustained ventricular tachycardia? Results of a meta-analysis. Am Heart J. 123:1992;481-485.
26. Epstein A.E., Hallstrom A.P., Rogers W.J., et al. Mortality following ventricular arrhythmia suppression by encainide, flecainide, and moricizine after myocardial infarction. The original design concept of the Cardiac Arrhythmia Suppression Trial (CAST). JAMA. 270:1993;2451-2455.
27. Preliminary report effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. The Cardiac Arrhythmia Suppression Trial (CAST) Investigators . [see comments]. N Engl J Med. 321:1989;406-412.
28. Julian D.G., Prescott R.J., Jackson F.S., Szekely P. Controlled trial of sotalol for one year after myocardial infarction. Lancet. 1:1982;1142-1147.
29. Waldo A., Camm A., deRuyter H., et al. Effect of d-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarction. Lancet. 348:1996;7-12.
30. Burkart F., Pfisterer M., Kiowski W., et al. Effect of antiarrhythmic therapy on mortality in survivors of myocardial infarction with asymptomatic complex ventricular arrhythmias Basel Antiarrhythmic Study of Infarct Survival (BASIS) . [see comments]. J Am Coll Cardiol. 16:1990;1711-1718.
31. Pfisterer M., Kiowski W., Burckhardt D., et al. Beneficial effect of amiodarone on cardiac mortality in patients with asymptomatic complex ventricular arrhythmias after acute myocardial infarction and preserved but not impaired left ventricular function. Am J Cardiol. 69:1992;1399-1402.
32. Pfisterer M.E., Kiowski W., Brunner H., et al. Long-term benefit of 1-year amiodarone treatment for persistent complex ventricular arrhythmias after myocardial infarction. [see comments]. Circulation. 87:1993;309-311.
33. Ceremuzynski L., Kleczar E., Krzeminska P.M., et al. Effect of amiodarone on mortality after myocardial infarction a double-blind, placebo-controlled, pilot study . [see comments]. J Am Coll Cardiol. 20:1992;1056-1062.
34. Cairns J.A., Connolly S.J., Gent M., Roberts R. Post-myocardial infarction mortality in patients with ventricular premature depolarizations Canadian Amiodarone Myocardial Infarction Arrhythmia Trial Pilot Study . Circulation. 84:1991;550-557.
35. Julian D., Camm A., Frangin G., et al. Randomized trial of effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction EMIAT . Lancet. 349:1997;667-674.
36. Cairns J., Connolly S., Roberts R., Gent M. Randomized trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarizations CAMIAT . Lancet. 349:1997;675-682.
37. Doval H.C., Nul D.R., Grancelli H.O., et al. Randomised trial of low-dose amiodarone in severe congestive heart failure. Grupo de Estudio de la Sobrevida en la Insuficiencia Cardiaca en Argentina (GESICA). [see comments]. Lancet. 344:1994;493-498.
38. Singh S.N., Fletcher R.D., Fisher S.G., et al. Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure. [see comments]. N Engl J Med. 333:1995;77-82.
39. Moss A.J., Hall W.J., Cannom D.S., et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. [see comments]. N Engl J Med. 335:1996;1933-1940.
40. Bigger J.T. Prophylactic use of implanted cardiac defibrillators in patients at high risk for ventricular arrhythmias after coronary-artery bypass surgery. N Engl J Med. 337:1997;1569-1575.
41. Buxton A.E., Fisher J.D., Josephson M.E., et al. Prevention of sudden death in patients with coronary artery disease the Multicenter Unsustained Tachycardia Trial (MUSTT) . Prog Cardiovasc Dis. 36:1993;215-226.
42. Buxton A.E., Lee K.L., DiCarlo L., et al. Nonsustained ventricular tachycardia in coronary artery disease relation to inducible sustained ventricular tachycardia. MUSTT Investigators . Ann Intern Med. 125:1996;35-39.
43. Effect of prophylactic amiodarone on mortality after acute myocardial infarction and in congestive heart failure meta-analysis of individual data from 6500 patients in randomised trials . Lancet. 350:1997;1417-1424.
44. Tchou P., Jazayeri M., Denker S., et al. Transcatheter electrical ablation of right bundle branch. A method of treating macroreentrant ventricular tachycardia attributed to bundle branch reentry. Circulation. 78:1988;246-257.
45. Page R.L., Shenasa H., Evans J.J., et al. Radiofrequency catheter ablation of idiopathic recurrent ventricular tachycardia with right bundle branch block, left axis morphology. PACE. 16:1993;327-336.
46. Klein L.S., Shih H.T., Hackett F.K., et al. Radiofrequency catheter ablation of ventricular tachycardia in patients without structural heart disease. Circulation. 85:1992;1666-1674.
47. Morady F., Harvey M., Kalbfleisch S.J., et al. Radiofrequency catheter ablation of ventricular tachycardia in patients with coronary artery disease. [see comments]. Circulation. 87:1993;363-372.
48. Mittleman R.S., Candinas R., Dahlberg S., et al. Predictors of surgical mortality and long-term results of endocardial resection for drug-refractory ventricular tachycardia. Am Heart J. 124:1992;1226-1232.
49. Garan H., Nguyen K., McGovern B., et al. Perioperative and long-term results after electrophysiologically directed ventricular surgery for recurrent ventricular tachycardia. J Am Coll Cardiol. 8:1986;201-209.
50. Gomes J.A., Hariman R.I., Kang P.S., et al. Programmed electrical stimulation in patients with high-grade ventricular ectopy electrophysiologic findings and prognosis for survival . Circulation. 70:1984;43-51.
51. Mitchell L.B., Duff H.J., Manyari D.E., et al. A randomized clinical trial of the noninvasive and invasive approaches to drug therapy of ventricular tachycardia. N Engl J Med. 317:1987;1681-1687.
52. Graboys T.B., Lown B., Podrid P.J., et al. Long-term survival of patients with malignant ventricular arrhythmia treated with antiarrhythmic drugs. Am J Cardiol. 50:1982;437-443.
53. Mason J.W. A comparison of electrophysiologic testing with Holter monitoring to predict antiarrhythmic-drug efficacy for ventricular tachyarrhythmias. Electrophysiologic Study versus Electrocardiographic Monitoring Investigators. [see comments]. N Engl J Med. 329:1993;445-451.
54. Mason J.W. A comparison of seven antiarrhythmic drugs in patients with ventricular tachyarrhythmias. Electrophysiologic Study versus Electrocardiographic Monitoring Investigators. [see comments]. N Engl J Med. 329:1993;452-458.
55. Randomized antiarrhythmic drug therapy in survivors of cardiac arrest (the CASCADE Study). The CASCADE Investigators. Am J Cardiol. 72:1993;280-287.
56. Steinbeck G., Andresen D., Bach P., et al. A comparison of electrophysiologically guided antiarrhythmic drug therapy with beta blocker therapy in patients with symptomatic, sustained ventricular tachyarrhythmias. N Engl J Med. 327:1992;987-992.
57. Powell A.C., Fuchs T., Finkelstein D.M., et al. Influence of implantable cardioverter-defibrillators on the long-term prognosis of survivors of out-of-hospital cardiac arrest. [see comments]. Circulation. 88:1993;1083-1092.
58. Newman D., Sauve M.J., Herre J., et al. Survival after implantation of the cardioverter defibrillator. [see comments]. Am J Cardiol. 69:1992;899-903.
59. Sweeney M.O., Ruskin J.N. Mortality benefits and the implantable cardioverter-defibrillator. Circulation. 89:1994;1851-1858.
60. Kim S.G. Implantable defibrillator therapy does it really prolong life? How can we prove it? [editorial] [see comments]. Am J Cardiol. 71:1993;1213-1218.
61. A comparison of antiarrhythmic-drug therapy with implantable defibrillators on patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med. 337:1997;1576-1583.
62. Siebels J., Cappato R., Ruppel R., et al. Preliminary results of the Cardiac Arrest Study Hamburg (CASH). CASH Investigators. Am J Cardiol. 72:1993;109F-113F.